Total Payments
$718.20
2024 Payments
$132.76
Companies
13
Transactions
35
Medicare Patients
2,112
Medicare Billing
$468,229
Payment Breakdown by Category
Food & Beverage$607.00 (84.5%)
Education$111.20 (15.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $607.00 | 34 | 84.5% |
| Education | $111.20 | 1 | 15.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $167.53 | 8 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $161.80 | 5 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $74.06 | 4 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $66.95 | 4 | $0 (2021) |
| Indivior Inc. | $46.63 | 3 | $0 (2023) |
| Lundbeck LLC | $39.44 | 2 | $0 (2024) |
| Alkermes, Inc. | $37.03 | 2 | $0 (2024) |
| ITI, Inc. | $33.06 | 2 | $0 (2023) |
| Orexo US, Inc. | $23.20 | 1 | $0 (2020) |
| Merck Sharp & Dohme LLC | $20.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $132.76 | 7 | ABBVIE INC. ($46.11) |
| 2023 | $211.96 | 11 | AbbVie Inc. ($91.96) |
| 2022 | $109.22 | 6 | Janssen Pharmaceuticals, Inc ($41.63) |
| 2021 | $63.62 | 3 | Sunovion Pharmaceuticals Inc. ($34.16) |
| 2020 | $23.20 | 1 | Orexo US, Inc. ($23.20) |
| 2019 | $13.72 | 1 | US WorldMeds, LLC ($13.72) |
| 2018 | $114.14 | 2 | Teva Pharmaceuticals USA, Inc. ($114.14) |
| 2017 | $49.58 | 4 | Sunovion Pharmaceuticals Inc. ($32.79) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: CNS | ||||||
| 09/17/2024 | Noven Therapeutics, LLC | Xelstrym (Drug), Secuado | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: ADHD | ||||||
| 07/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: PSYCHIATRY | ||||||
| 06/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Neurology | ||||||
| 02/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.80 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Neurology | ||||||
| 09/19/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Neuroscience | ||||||
| 07/25/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Neuroscience | ||||||
| 07/11/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: BH | ||||||
| 04/04/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: PSYCHIATRY | ||||||
| 03/15/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: BH | ||||||
| 02/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.73 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: BH | ||||||
| 11/29/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: CNS | ||||||
| 10/18/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Neuroscience | ||||||
| 08/23/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Neuroscience | ||||||
| 06/14/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: PSYCHIATRY | ||||||
| 05/25/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.64 | General |
| Category: PSYCHIATRY | ||||||
| 06/29/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 453 | 1,588 | $293,370 | $97,953 |
| 2022 | 7 | 511 | 1,958 | $352,250 | $113,940 |
| 2021 | 7 | 516 | 1,691 | $322,545 | $112,358 |
| 2020 | 7 | 632 | 2,574 | $446,220 | $143,978 |
Total Patients
2,112
Total Services
7,811
Medicare Billing
$468,229
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 66 | 445 | $97,900 | $29,747 | 30.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 47 | 517 | $56,870 | $19,710 | 34.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 96 | 319 | $47,850 | $18,843 | 39.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 59 | 95 | $34,200 | $10,088 | 29.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 78 | 79 | $27,650 | $9,001 | 32.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 80 | 96 | $14,400 | $5,798 | 40.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 37 | $14,500 | $4,766 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 85 | 573 | $126,060 | $40,136 | 31.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 111 | 505 | $75,750 | $27,070 | 35.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 57 | 569 | $62,590 | $17,026 | 27.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 81 | 81 | $28,350 | $9,438 | 33.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 39 | 55 | $21,700 | $7,716 | 35.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 95 | 120 | $18,000 | $6,692 | 37.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 43 | 55 | $19,800 | $5,861 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 86 | 606 | $134,545 | $45,030 | 33.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 116 | 587 | $86,280 | $31,751 | 36.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 106 | 106 | $36,775 | $13,714 | 37.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 103 | 123 | $18,310 | $6,684 | 36.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 43 | 200 | $21,240 | $6,027 | 28.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 36 | 40 | $15,290 | $5,938 | 38.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 26 | 29 | $10,105 | $3,213 | 31.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 131 | 952 | $114,240 | $52,203 | 45.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 115 | 746 | $182,770 | $41,357 | 22.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 58 | 458 | $45,800 | $13,757 | 30.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 49 | 71 | $18,460 | $10,465 | 56.7% |
About Dr. Srinivas Battula, MD
Dr. Srinivas Battula, MD is a Psychiatry healthcare provider based in Saint Peters, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093729311.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Srinivas Battula, MD has received a total of $718.20 in payments from pharmaceutical and medical device companies, with $132.76 received in 2024. These payments were reported across 35 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($607.00).
As a Medicare-enrolled provider, Battula has provided services to 2,112 Medicare beneficiaries, totaling 7,811 services with total Medicare billing of $468,229. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Saint Peters, MO
- Active Since 07/29/2006
- Last Updated 01/11/2021
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1093729311
Products in Payments
- VRAYLAR (Drug) $167.53
- INVEGA SUSTENNA (Drug) $74.06
- LATUDA (Drug) $66.95
- REXULTI (Drug) $58.00
- PERSERIS (Drug) $46.63
- CAPLYTA (Drug) $33.06
- UZEDY (Drug) $30.87
- Zubsolv (Drug) $23.20
- BELSOMRA (Drug) $20.00
- ARISTADA (Drug) $19.80
- LYBALVI (Drug) $17.23
- SD809-TD (Drug) $16.79
- Xelstrym (Drug) $16.22
- Lucemyra/Lofexidine (Drug) $13.72
- AUSTEDO (Drug) $2.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Saint Peters
Satish Kulkarni, Md, MD
Psychiatry — Payments: $19,489
Psychiatry $19,489
Dr. Chinya Murali, Md, MD
Psychiatry — Payments: $8,299
Psychiatry $8,299
Dr. Roomana Arain, M.d, M.D
Psychiatry — Payments: $3,993
Psychiatry $3,993
Dr. Raafea Malik, M.d, M.D
Psychiatry — Payments: $2,123
Psychiatry $2,123
Thripura Thirtala, M.d, M.D
Psychiatry — Payments: $2,057
Psychiatry $2,057
Dawn Holemon, M.d, M.D
Psychiatry — Payments: $191.24
Psychiatry $191.24